Texas just passed a bill that could jail you for a gummy. House Bill 3948 criminalizes THC above 0.3 percent, targeting vapes, edibles, and Delta-8 under the guise of regulation. While the nation moves forward, Texas slams into reverse, fast and hard.
From Court to Cannabis: The Jarred Shaw Saga
Jarred Shaw is facing execution in Indonesia for allegedly importing THC gummies. This hard-edged feature exposes the brutal disconnect between American cannabis normalization and global drug laws, where edibles can mean death. A raw look at the price of ignorance across borders.
DEA Stalls on Cannabis Rescheduling: What’s the Hold-Up?
The DEA is dragging its feet on cannabis rescheduling despite over 43,000 public comments and a formal Schedule III recommendation from HHS. What’s the hold-up? This deep-dive exposes the legal limbo, political stall tactics, and why America’s weed policy is still frozen in time.
Tommy Chong Returns to Raise Hell at Hash Bash
The Ann Arbor Hash Bash, held annually since 1972, symbolizes the ongoing fight for cannabis rights and culture. Headlined by Tommy Chong in 2025, it embodies protest and celebration against restrictive drug laws. The event attracts diverse generations, emphasizing the fight for freedom and autonomy amid the commercialization of cannabis culture.
BREAKING: DEA Reclassifies Marijuana as a Vegetable
In a bizarre twist of bureaucratic brilliance, the DEA has reclassified marijuana as a leafy green vegetable—officially adding it to the American food pyramid. From salad bowls to school lunches, the War on Drugs just got edible. Satirical? Yes. Unbelievable? Barely.
The DEA’s Stance on Rescheduling: Progress or Stalemate?
The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.